Note: Ingredients listed on restricted chemical lists
EC/CAS
919-857-5/64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
30 - 50
EC/CAS
223-296-5/3811-73-2
Name of the chemical
Pyridine-2-thiol 1-oxide, sodium salt
Concentration
<0.1
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.1
General Information
Version
2.0
Revision date
2024-07-17
Product name
according to the REACH Regulation (EC)
Emergency telephone
GB & EU +44 (0) 845 600 3663
Icons in SDS
Company Information
company name
Turtle Wax Europe Limited
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS@turtlewax.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H336
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Causes serious eye irritation. May cause drowsiness or dizziness.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Contains
Hydrocarbons, c9-c11, n-alkanes, isoalkanes, cyclics, < 2% aromatics
Hazard statements
H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.
Precautionary statements
P102 - Keep out of reach of children. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear eye protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents / container in accordance with local / national regulations.
Supplemental label elements
EUH208 - Contains BENZISOTHIAZOLINONE. May produce an allergic reaction. Child-resistant fastening : Not applicable Tactile warning : Not applicable
Other hazards which do not result in classification
None under normal conditions. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
